Pliant Therapeutics PLRX
NASDAQ PLRX
$0.89 -0.03 (-2.92%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) EV to EBIT (2020)

Updated

Pliant Therapeutics' (PLRX) EV to EBIT was 25.99 for Q3 2020, up 597.6% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) EV to EBIT (2020) Analysis & Trends

Over the twelve months ended Sep 30, 2020, Pliant Therapeutics' EV to EBIT came in at 41.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Pliant Therapeutics 54.57 Mn -707.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 25.99
Jun 30, 2020 3.73
API Access

Pliant Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=PLRX&period=max&api_key=YOUR_API_KEY